Additional clinical and real-world data from the industry’s largest and broadest amyloidosis pipeline will advance understanding of underlying mechanisms of disease and unmet needs Christophe ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the first-ever recommendations for patient- and family-centred ...

Living with hATTR-PN can be challenging, both physically and emotionally. However, multiple resources can offer treatment support, financial help, and ways to connect with others. Hereditary ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...

Dialysis patients often develop dialysis-related amyloidosis and exhibit bone and joint disorders that impair their activity of daily living. Blood purification devices consisting of ...

This one-hour on-demand video learning module features a panel of expert multidisciplinary providers who specialize in the treatment of ATTR (Transthyretin) Amyloidosis. Their discussion includes a ...

Researchers have identified a link between amyloid plaques and dysfunctional neuronal conduction in animal models of Alzheimer’s disease (AD). Their study, which was published in the Dec. 1, 2022, ...

An international team led by researchers at the University of Toronto has developed an efficient and robust system, using the C. elegans nematode, to screen for compounds that can stop the growth of ...

Summary: A new study demonstrates that the BCG vaccine actively remodels the immune environment surrounding the human brain and spinal cord. By tracking older adults over 12 months, the research team ...

I am so proud to have contributed to the development of these recommendations so that they reflect not only my experience as someone living with the condition, but those of the broader patient ...